Literature DB >> 28869375

Treatment strategies for craniopharyngiomas.

Malte Ottenhausen1, Kavelin Rumalla1, Emanuele La Corte1, Andrew Alalade1, Prakash Nair1, Jonathan Forbes1, Atef Ben Nsir1, Theodore H Schwartz2.   

Abstract

Craniopharyniomas arise from the sellar region and are particularly challenging because of their close proximity to critical neurovascular structures, including cranial nerves, brainstem, internal carotid arteries, posterior cerebral arteries, hypothalamus, and the pituitary gland. The tumors are benign on histology but can cause serious symptoms by compression of surrounding vital structures. While radical surgery and gross total resection (GTR) remains the first line treatment, choosing the optimal surgical approach is critical for the minimization of complications and postoperative morbidity. The extended endoscopic endonasal approach (EEEA) offers a direct route towards the sellar and suprasellar regions and has proven to be a safe and effective for GTR, with lower rates of complications and postoperative morbidity than open transcranial approaches. However, traditional transcranial approaches remain relevant in tumors with significant lateral extension. Radiotherapy can be considered in cases of subtotal resection (STR) or if surgery is not possible, although progressive growth of cysts with neurological deterioration has been demonstrated no infrequently. Newly developed chemotherapy for papillary craniopharygniomas might expand treatment options in the future.

Entities:  

Mesh:

Year:  2017        PMID: 28869375     DOI: 10.23736/S0390-5616.17.04171-6

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  4 in total

1.  BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series.

Authors:  Emanuele La Corte; Iyan Younus; Francesca Pivari; Adelina Selimi; Malte Ottenhausen; Jonathan A Forbes; David J Pisapia; Georgiana A Dobri; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

2.  Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.

Authors:  Antonio Martínez-Ortega; Álvaro Flores-Martinez; Eva Venegas-Moreno; Elena Dios; Diego Del Can; Eloy Rivas; Ariel Kaen; Eugenio Cárdenas Ruiz-Valdepeñas; Elena Fajardo; Florinda Roldán; Natividad González-Rivera; Rosario Oliva; José Ignacio Fernández-Peña; Alfonso Soto-Moreno; David A Cano
Journal:  J Clin Med       Date:  2022-01-05       Impact factor: 4.241

Review 3.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

4.  Stereotactic cysto-ventricular catheters in craniopharyngiomas: an effective minimally invasive method to improve visual impairment and achieve long-term cyst volume reduction.

Authors:  Christine Steiert; Juergen Grauvogel; Roland Roelz; Theo Demerath; Daniel Schnell; Juergen Beck; Volker Arnd Coenen; Peter Christoph Reinacher
Journal:  Neurosurg Rev       Date:  2021-03-05       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.